ITEMS OF INTEREST TO THE IMAGING RESEARCH COMMUNITY:
CIP Web Site: http://www.cancer.gov/bip
- NIH REGIONAL SEMINAR IN PROGRAM FUNDING AND GRANTS ADMINISTRATION FOR 2002 TO BE HELD JUNE 6 AND 7 (NOT-OD-02-048)
Are you relatively new to NIH funding? NIH holds two seminars a year that are designed to help research faculty and administrators learn the system.
- SOCIETY OF NUCLEAR MEDICINE, June 15-19, 2002, Los Angeles, California; NCI Cancer Imaging Program Booth No. 112; Dr. Hoffman and Croft from CIP and Dr. Kathryn Morton, WFMS, are giving a continuing education session, entitled "Research Grant Funding," Tuesday, June 18, at 2:30 PM.
- AAPM WORKSHOP ON GRANTSMANSHIP; July 19, 2002 (After the AAPM Montreal Meeting); Mont-Tremblant, Quebec
- First Annual Meeting of the SOCIETY OF MOLECULAR IMAGING, August 24-26, 2002, Boston, Massachusetts
- SECOND INTERNATIONAL SYMPOSIUM ON TUMOR TARGETED DELIVERY SYSTEMS, September 22-25, 2002 Bethesda, Maryland
- ACADEMY OF MOLECULAR IMAGING 2002 Annual Conference, October 23-27, 2002 at the Sheraton Hotel and Marina, San Diego, California.
- RESTRUCTURING OF NIH REVIEW PANELS. Surgical Sciences, Biomedical Imaging and Bioengineering IRG restructuring report. Look at this and comment.
Comments page for SBIB: http://www.csr.nih.gov/PSBR/SAIAB/SBIB_Intro.htm
Look at BST IRG : http://www.csr.nih.gov/PSBR/BST/BST.pdf for comparison
- UPDATE ON THE TRANSITION TO ELECTRONIC NON-COMPETING GRANT PROGRESS REPORT NOTIFICATION (NOT-OD-02-047)
NIH continues to transition the notification of Non-Competing Grant Progress Reports from a hard copy mailing of preprinted electronic PHS 2590 and PHS 416 face pages to an electronic notification. To facilitate this transition, NIH will continue mailing pre-printed type 5 face pages for awards with start dates through November 2002. November provides a two-month extension from the previously announced cessation date to allow grantees and NIH staff time to transition to the new business practices.
- INTERAGENCY COUNCIL ON BIOMEDICAL IMAGING IN ONCOLOGY
Announcement and Call for Requests
Next Due Date for Requests - Monday, June 10, 2002 (for July 22, 2002 meeting)
The National Cancer Institute (NCI), Food and Drug Administration (FDA), and Centers for Medicare and Medicaid Services (CMS, formerly known as the Health Care Financing Administration) are pleased to announce that the seventh meeting of the Interagency Council on Biomedical Imaging in Oncology will take place on July 22, 2002. The Council is a multi-agency group designed to serve as a sounding board for investigators and manufacturers attempting to take emerging medical imaging technology to market.
- NIH NATIONAL RESEARCH SERVICE AWARD INSTITUTIONAL RESEARCH TRAINING GRANTS (T32) (PA-02-109)
The National Institutes of Health (NIH) will award National Research Service Award (NRSA) Institutional Training Grants (T32) to eligible institutions to develop or enhance research training opportunities for individuals, selected by the institution, who are training for careers in specified areas of biomedical, behavioral, and clinical research. The NIH institutes and centers may have special policies and requirements for their Institutional Research Training Grants (T32), so applicants should contact the prospective NIH awarding component listed at the end of this announcement to discuss their specific policies.
- The Office for Human Research Protections (OHRP) has posted guidance regarding written Institutional Review Board (IRB) procedures. To assist institutions in developing adequate written IRB procedures, OHRP has compiled a summary of the relevant regulatory requirements and guidance issued routinely by OHRP over the past several years.
- FDA SEEKS COMMENT ON WHETHER TO REQUIRE SPONSORS AND INVESTIGATORS TO INFORM INSTITUTIONAL REVIEW BOARDS (IRBS) OF ANY PRIOR IRB REVIEWS.
The Food and Drug Administration (FDA) published in the Federal Register an Advance Notice of Proposed Rulemaking seeking information on IRB practices to determine whether to draft a regulation to require sponsors and investigators to inform IRBs about any prior IRB review decisions. Comments on the notice are due by June 4, 2002.
- NIH-NSF BIOENGINEERING AND BIOINFORMATICS SUMMER INSTITUTES PROGRAM (BBSI) (NOT-EB-02-003)
FULL PROPOSAL DEADLINE: June 27, 2002
NSF and NIH will make joint awards to develop and conduct ten-week "Summer Institutes" aimed at providing upper-level undergraduate and lower-level graduate students majoring in the biological, computational, engineering, mathematics, or physical sciences with well-planned, inter-disciplinary bioengineering or bioinformatics research and education experiences.
URL: http://grants.nih.gov/grants/guide/notice-files/NOT-EB-02-003.html and http://www.nsf.gov/pubsys/ods/getpub.cfm?nsf02109
- PRECLINICAL EVALUATION OF INTERMEDIATE ENDPOINTS AND THEIR MODULATION BY CHEMOPREVENTIVE AGENTS (NCI)
The National Cancer Institute, Division of Cancer Prevention, (DCP) Chemoprevention Agent Development Research Group (CADRG) is interested in conducting animal cancer model studies of biomarkers and intermediate endpoints that might be used in human clinical trials in order to examine in detail the biomarker modulating effects of selected chemopreventive compounds. In addition the studies will improve biomarker sensitivity, specificity, assay methodology, and sample handling. Click on the "Current Requests for Proposals" link and locate RFP/N01-CN-85052-72 under Master Agreement Announcements.
- NIBIB NATIONAL RESEARCH SERVICE AWARDS FOR INDIVIDUAL POSTDOCTORAL FELLOWS (F32) (NOT-EB-02-001)
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) will award National Research Service Award (NRSA) Individual Postdoctoral Fellowships (F32) to promising applicants with the potential to become productive, independent investigators in fields related to the mission of the NIBIB.
- NIBIB NATIONAL RESEARCH SERVICE AWARD INSTITUTIONAL RESEARCH TRAINING GRANTS(T32) (NOT-EB-02-002)
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) will award National Research Service Award (NRSA) Institutional Training Grants (T32) to eligible institutions to develop or enhance research training opportunities for individuals, selected by the institution, who are training for careers in multi-disciplinary research concerned with biology and medicine. See the announcement for PA-02-109 above.
- CHEMOPREVENTION OF TOBACCO-RELATED CANCERS IN FORMER SMOKERS: CLINICAL STUDIES (NCI) (RFA-CA-03-006)
Letter of intent receipt date: June 21, 2002; application receipt date: July 26, 2002
The purpose of this initiative is to fund clinical research to develop effective chemopreventive strategies that reduce the risk of tobacco-related cancers in former smokers.
- TECHNOLOGY DEVELOPMENT FOR BIOMEDICAL APPLICATIONS: PHASED INNOVATION AWARD (NCRR, NHGRI, NIBIB)(R21/R33) (PAR-02-091)
APPLICATION RECEIPT DATES: June 1, and October 1 annually
The purpose of this program announcement (PA) is to invite innovative applications for (1) the development of new and improved instruments or devices, (2) the development of new methodologies using existing instruments, or (3) the development of software to be used in biomedical research.
Other Government Agenices
- FDA DRAFT REGULATION AND DRAFT GUIDANCE
There are 2 documents from the FDA currently available for comment. They are Current Good Manufacturing Practice for Positron Emission Tomography Drug Products; Preliminary Draft Proposed Rule (comments by June 5, 2002) and Draft Guidance on Good Manufacturing Practice for Positron Emission Tomography Drug Products.
- FACULTY EARLY CAREER DEVELOPMENT (CAREER) PROGRAM (NSF) (NSF02111)
The Faculty Early Career Development (CAREER) Program is a Foundation-wide activity that offers the National Science Foundation's most prestigious awards for new faculty members. The CAREER program recognizes and supports the early career-development activities of those teacher-scholars who are most likely to become the academic leaders of the 21st century.
Frequently Asked Questions (FAQs) about the Faculty Early Career Development (CAREER) Program at URL: http://www.nsf.gov/cgi-bin/getpub?nsf02113
- FY 2002 ADVANCED TECHNOLOGY PROGRAM (NIST)
Deadlines: 5/2/2002; 6/10/2002; 7/31/2002; 9/30/2002
The National Institute of Standards and Technology (NIST) announces that it will hold a single fiscal year 2002 Advanced Technology Program (ATP) competition and announces a public meeting (Proposers' Conference) for all interested parties. This single competition will continue ATP's practice of being open to all technology areas. All fiscal year 2002 proposals received may be distributed to technology-specific source evaluation boards in areas such as advanced materials, biotechnology, electronics, information technology, etc.
- CHARLOTTE GEYER FOUNDATION
The Charlotte Geyer Foundation provides interim funding to researchers whose proposals have been reviewed by the National Cancer Institute and were ranked within ten percentage points of the NCI payline.
- CHARLES E. CULPEPER SCHOLARSHIPS IN MEDICAL SCIENCE
The Rockefeller Brothers Fund is pleased to announce the continuation of a scholarship program to support the career development of academic physicians. Nominations will be accepted until August 15, 2002. Up to four awards of $100,000 per year for up to three years will be made to United States medical schools or equivalent United States educational institutions on behalf of candidates.
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.
If you wish to remain on the list, no action is necessary. If you wish to be added to the list (or removed from it), please contact Ms. Johnnie Smith by return e-mail (email@example.com).
Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
EPN, Room 6000 - MSC-7412
6130 Executive Boulevard
Bethesda, MD 20892-7440
Tel: 301 496 9531
Fax: 301 480 3507